Compare · head to head
CSL vs Samsung Epis
CSL ranks higher overall — 360 rank 40 vs 20.
CSL leads on Value (65 vs 53), Quality (64 vs 50) and Safety (44 vs 33). Samsung Epis leads on Growth (45 vs 26). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Australia | South Korea |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | X-Large | Small |
| ISIN | AU000000CSL8 | KR70126Z0002 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 40 | 20 |
| Value | 65 | 53 |
| Quality | 64 | 50 |
| Growth | 26 | 45 |
| Safety | 44 | 33 |
| Sentiment | 39 | 36 |
| Quality details | ||
| Profitability | 59 | 50 |
| Cash Truth | 68 | 50 |
Full analyses: CSL · Samsung Epis
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100